Alpha Thalassemia/Mental Retardation Syndrome X-Linked (ATRX) loss is frequently identified in gliomas and may be a molecular marker for DNA damage response defects and ATRX knock-out led to PARP inhibitor sensitivity in glioma cells [50]. Here, PARP1 is linked to glioma.